Latent membrane protein 1 encoded by Epstein-Barr virus modulates directly and synchronously cyclin D1 and p16 by newly forming a c-Jun/Jun B heterodimer in nasopharyngeal carcinoma cell line

Virus Research

Volumn 113, Issue 2, 2005, Pages 89-99

  Song, X ^a,f   Tao, Y G ^a   Zeng, L ^a   Deng, X Y ^b   Lee, L M ^c   Gong, J P ^d   Wu, Q ^e   Cao, Y ^a  

^a Central South University   (China)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAIC FREDERICK INC   (United States)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e XIAMEN UNIVERSITY   (China)

^f SUN YAT SEN UNIVERSITY   (China)

Author keywords

Activator protein 1; c Jun; Cell cycle; Cyclin D1; Epstein Barr virus; Heterodimer; Jun B; Latent membrane protein 1; Nasopharyngeal carcinoma; p16

Indexed keywords

CYCLIN D1; LATENT MEMBRANE PROTEIN 1; PROTEIN C JUN; PROTEIN P16;

ANTIGEN EXPRESSION; ARTICLE; CARCINOMA CELL; CELL CYCLE; DOWN REGULATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; MALADJUSTMENT; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CARCINOMA; CELL CYCLE; CELL LINE; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DIMERIZATION; DOXYCYCLINE; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROMOTER REGIONS (GENETICS); PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-JUN; SIGNAL TRANSDUCTION; TRANSFECTION; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 24944483193     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2005.04.019     Document Type: Article

References (79)

1. N. Arber, H. Hibshoosh, and S.F. Moss Increased expression of Cyclin D1 is an early event in multistagecolorectal carcinogenesis Gastroenterology 110 1996 669 674
2. N.C. Andrews, and D.V. Faller A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells Nucleic Acids Res. 19 1991 2499
3. Y. Baba, M. Tsukuda, and I. Mochimatsu Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma Cancer Detect. Prev. 25 2001 414 419
4. L. Bakiri, D. Lallemand, and B.W. Ella Cell cycle-dependent variations in c-Jun and Jun B phosphorylation: a role in the control of cyclin D1 expression EMBO J. 19 2000 2056 2068
5. J. Bartek, J. Bartkova, and J. Lukas The retinoblastoma protein pathway and the restriction point Curr. Opin. Cell Biol. 8 1996 805 814
6. J. Bartek, J. Lukas, and J. Bartkova Perspective: defects in cell cycle control and cancer J. Pathol. 187 1999 95 99
7. M.B. Beasley, S. Lantuejoul, and S. Abbondanzo The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung Hum. Pathol. 34 2003 136 142
8. E.M. Bindels, F. Lallemand, and A. Balkenende Involvement of G1/S cyclins in estrogen-independent proliferation of estrogen receptor-positive breast cancer cells Oncogene 21 2002 8158 8165
9. E. Bossy-Wetzel, L. Bakiri, and M. Yaniv Induction of apoptosis by the transcription factor c-Jun EMBO J. 16 1997 1695 1709
10. M.R. Briggs, J.T. Kadonaga, and S.P. Bell Purification and biochemical characterization of the promoter-specific transcription factor SP1. Sci. 234 1986 47 52
11. E. Chalaux, T. Lopez-Rovira, and J.L. Rosa Jun B is involved in the inhibition of myogenic differentiation by bone morphogenetic protein-2 J. Biol. Chem. 273 1998 537 543
12. H.W. Chang, A. Chan, and D.L. Kwong Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient Int. J. Cancer. 105 2003 851 855
13. N.R. Chapman, and N.D. Perkins Inhibition of the RelA(p65) NF-kappaB subunit by Egr-1 J. Biol. Chem. 275 2000 4719 4725
14. R. Chiu, P. Angel, and M. Karin Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun Cell 59 1989 979 986
15. L.S. Chow, X. Wang, and D.L. Kwong Effect of p16INK4a on chemosensitivity in nasopharyngeal carcinoma cells Int. J. Oncol. 17 2000 135 140
16. P. Delerive, K. De Bosscher, and S. Besnard Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1 J. Biol. Chem. 274 1999 32048 32054
17. L. Deng, J. Yang, and X.R. Zhao Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-kappaB and AP-1 Cell Res. 13 2003 187 194
18. T. Deng, and M. Karin Jun B differs from c-Jun in its DNA-binding anddimerization domains, and represses c-Jun By formation of inactive heterodimer Genes Dev. 7 1993 479 490
19. D. Donjerkovic, and D.W. Scott Regulation of the G1 phase of the mammalian cell cycle Cell Res. 10 2000 1 16
20. A.G. Eliopoulos, and L.S. Young Activation of the c-Jun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein1 (LMP1) Oncogene 16 1998 1731 1742
21. T.A. Engler, K. Furness, and S. Malhotra Novel, potent and selective cyclin D1/CDK4inhibitors: indolo[6,7-a]pyrrolo[3 4-c]carbazoles Bioorg. Med. Chem. Lett. 13 2003 2261 2267
22. M. Gadd, C. Pisc, and J. Branda Regulation of cyclin D1 and p16 is critical for growth arrest during mammary involution Cancer Res. 61 2001 8811 8819
23. M.L. Gulley, J.M. Nicholls, and B.G. Schneider Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product Am. J. Pathol. 152 1998 865 869
24. D.C. Guttridge, C. Albanese, and J.Y. Reuther NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1 Mol. Cell Biol. 19 1999 5785 5799
25. E. Hara, R. Smith, and D. Parry Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence Mol. Cell Biol. 16 1996 859 867
26. B. Herber, M. Truss, and M. Beato Inducible regulatory elements in the human cyclin D1 promoter Oncogene 9 1994 2105 2107
27. M. Hinz, D. Krappmann, and A. Eichten NF-κB function in growth control: regulation of cyclin D 1 expression and G0/G1 to S-phase transition MCB 19 1999 2690 2698
28. G.W. Huang, W.N. Mo, and G.Q. Kuang Expression of p16, nm23-H1, E-cadherin, and CD44 gene products and their significance in nasopharyngeal carcinoma Laryngoscope 111 2001 1465 1471
29. J.G. Izzo, V.A. Papadimitrakopoulou, and X.Q. Li Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification Oncogene 17 1998 2313 2322
30. S.M. Jacobs-Helber, R.M. Abutin, and C. Tian Role of Jun B in erythroid differentiation J. Biol. Chem. 277 2002 4859 4866
31. S. Jefferies, S.M. Edwards, and R.A. Hamoudi No germline mutations in CDKN2A (p16) in patients with squamous cell cancer of the head and neck and second primary tumours Br. J. Cancer 85 2001 1383 1386
32. V.D. Leaner, I. Kinoshita, and M.J. Birrer AP1 complexes containing c-Jun and Jun B cause cellular transformation of ratla fibroblasts and share transcriptional targets Oncogene 28 2003 5619 5629
33. A.W. Lee, J.H. Li, and W. Shi p16 gene therapy: a potentially efficacious modality for nasopharyngeal carcinoma Mol. Cancer Ther. 2 2003 961 969
34. W. Lee, P. Mitchell, and R. Tjian Purified transcription factor AP1 interacts with TPA-inducible enhancer elements Cell 49 1987 741 752
35. Z.K. Li, L. Xie, and Z.W. He Application of the differential hybridization of cDNA expression arrays technique in the identification of differentially expressed genes between nasopharyngeal carcinoma and normal nasopharyngeal tissue Chin. Sci. Bull. 16 1998 2462 2463
36. W. Liao, M. Tang, and J.J. Li Epstein-Barr virus encoded latent membrane protein 1 increases expression of immunoglobulin kappa light chain through NFkappaB in a nasopharyngeal carcinoma cell line Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 31 1999 659 663
37. W. Liao, H. Yi, and X.Y. Li Doxycycline dependent expression of Epstein-Barr virus latent membrane protein 1 with Tet regulating system in nasopharygeal carcinoma cell line Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 31 1999 309 312
38. W. Liao, M. Tang, and L.Q. Yin EBV latent membrane protein 1 induces p53 expression via NF-KB in nasopharyngeal carcinoma Zhonghua Zhongliu Zazhi 23 2001 199 201
39. K.W. Lo, D.P. Huang, and K.M. Laup p16 gene alterations in nasopharyngeal carcinoma Cancer Res. 55 1995 2039 2043
40. K.W. Lo, S.T. Cheung, and S.F. Leung Hypermethylation of the p16 gene in nasopharyngeal carcinoma Cancer Res. 56 1996 2721 2725
41. J. Lukas, L. Aagaard, and M. Strauss Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control Cancer Res. 55 1995 4818 4823
42. A.A. Makitie, C. MacMillan, and J. Ho Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma Clin. Cancer Res. 9 2003 2177 2184
43. X. Mao, G. Orchard, and D.M. Lillington Amplification and overexpression of Jun B is associated with primary cutaneous T-cell lymphomas Blood 101 2003 1513 1519
44. S. Mathas, M. Hinz, and I. Anagnostopoulos Aberrantly expressed c-Jun and Jun B are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B EMBO J. 21 2002 4104 4113
45. M. Molinari Cell cycle checkpoints and their inactivation in human cancer Cell Prolif. 33 2000 261 274
46. C.J. Nelsen, D.G. Rickheim, and N.A. Timchenko Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo Cancer Res. 61 2001 8564 8568
47. V.A. Papadimitrakopoulou, J. Izzo, and L. Mao Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development Clin. Cancer Res. 7 2001 3127 3134
48. E. Passegue, W. Jochum, and M. Schorpp-Kistner Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking Jun B expression in the myeloid lineage Cell 104 2001 21 32
49. INK4a expression EMBO J. 19 2000 2969 2979
50. W.J. Petty, K.H. Dragnev, and E. Dmitrovsky Cyclin D1 as a target for chemoprevention Lung Cancer Suppl. 1 2003 S155 S161
51. C.M. Robinson, S.S. Prime, and S. Huntley Overexpression of Jun B in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation Int. J. Cancer 91 2001 625 630
52. A.I. Robles, F. Larcher, and R.B. Whalin Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia Proc. Natl. Acad. Sci. 93 1996 7634 7638
53. A. Sarasin An overview of the mechanisms of mutagenesis and carcinogenesis Mutat. Res. 544 2003 99 106
54. M. Sartor, H. Steingrimsdottir, and F. Elamin Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines Clin. Cancer. Res. 7 2001 3127 3134
55. K.H. Schlingensiepen, R. Schlingensiepen, and M. Kunst Opposite functions of jun-B and c-jun in growth regulation and neuronal differentiation Dev. Genet. 14 1993 305 312
56. C.J. Sherr D-type cyclins Trends Biochem. Sci. 20 1995 187 190
57. J. Sherr Cancer cell cycle Science 274 1996 1672 1677
58. E. Shibosawa, K. Tsutsumi, and I. Koizuka Absence of nuclear p16 from Epstein-Barr virus-associated undifferentiated nasopharyngeal carcinomas Laryngoscope 110 2000 93 97
59. L.M. Smith, S.C. Wise, and D.T. Hendricks c-Jun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype Oncogene 18 1999 6063 6070
60. X. Song, Y.G. Tao, and Y. Cao Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1 Cell. Signal. 16 2004 1153 1162
61. Y. Sun, A. Hildesheim, and A.E. Lanier No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas Oncogene 10 1995 785 788
62. A. Szabowski, N. Maas-Szabowski, and S. Andrecht c-Jun and Jun B antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin Cell 103 2000 745 755
63. S.W. Tam, A.M. Theodoras, and J.W. Shay Differential expression and regulation of cyclin D1 protein in normal and tumor human cells:association with Cdk4 is required for cyclin D1 function in G1 progression Oncogene 9 1994 2663 2674
64. D. Vallone, S. Battista, and G.M. Pierantoni Neoplastic transformation of rat thyroid cells requires the Jun B and fra-1 gene induction which is dependent on the HMGI-C gene product EMBO J. 16 1997 5310 5321
65. J.F. Viallard, F. Lacombe, and F. Belloc Molecular mechanisms controlling the cell cycle: fundamental and implications for oncology Cancer Radiother. 5 2001 109 129
66. P.K. Vogt The oncoprotein Oncogene 20 2001 2365 2377
67. C. Wang, M.D. Ai, and W. Ren Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma Chin. Med. J. (Engl.) 116 2003 1022 1028
68. C. Wang, X. Deng, and X. Li Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus LMP1 via NF-kappa B or AP-1 signaling pathway in nasopharyngeal carcinoma cells Zhonghua Zhong Liu Za Zhi 24 2002 9 13
69. G..L. Wang, K.W. Lo, and K.S. Tsang Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma Br. J. Cancer 81 1999 1122 1126
70. N. Wang, L. Verna, and S. Hardy c-Jun triggers apoptosis in human vascular endothelial cells Circ. Res. 85 1999 387 393
71. R. Wisdom, R.S. Johnson, and C. Moore c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms EMBO J. 18 1999 188 197
72. L. Xie, L.G. Xun, and Z.W. He Application of the differential hybridization of tumor cDNA arrays technique in the identification of expressed genes in the nasopharyngeal carcinoma Prog. Nat. Sci. 10 2000 378 382
73. C.C. Yang, K.C. Chu, and H.Y. Chen Expression of p16 and cyclin D1 in bladder cancer and correlation in cancer progression Urol. Int. 69 2002 190 194
74. J. Yang, L. Deng, and X. Song Epstein-Barr virus inhibits p16INK4a expression in human fetal nasopharyngeal epithelial cells escaping from the replicative senenscence Shi Yan Sheng Wu Xue Bao 36 2003 215 220
75. L. Yin, W. Liao, and X Deng LMP1 activates NF-kappa B via degradation of I kappa B alpha in nasopharyngeal carcinoma cells Chin. Med. J. (Engl.) 114 2001 718 722
76. X.R. Zhao, H.H. Gu, and X.X. Weng The primary study on expression and function of D-Type cyclin in nasopharyngeal carcinoma cell lines Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao 32 2000 192 196
77. X.R. Zhao, C.X. Wang, and F.J. Luo Further study on cyclin D1expression and runction and function in human nasopgaryngeal carcinoma cell line Zhong hua Zhong Liu Za Zhi 23 2001 373 375
78. B.B. Zhou, and S.J. Elledge The DNA damage response: putting checkpoints in perspective Nature 408 2000 433 439
79. G. Zhu, S.E. Conner, and X. Zhou Synthesis, structure-activity relationship, and biological studies of indolocarbazoles as potent cyclin D1-CDK4 inhibitors J. Med. Chem. 46 2003 2027 2030